HomeCompareTRXPF vs YUM

TRXPF vs YUM: Dividend Comparison 2026

TRXPF yields 3.27% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRXPF wins by $634.83M in total portfolio value
10 years
TRXPF
TRXPF
● Live price
3.27%
Share price
$24.57
Annual div
$0.80
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$634.94M
Annual income
$599,684,359.43
Full TRXPF calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — TRXPF vs YUM

📍 TRXPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRXPFYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRXPF + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRXPF pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRXPF
Annual income on $10K today (after 15% tax)
$277.78/yr
After 10yr DRIP, annual income (after tax)
$509,731,705.52/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, TRXPF beats the other by $509,697,741.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRXPF + YUM for your $10,000?

TRXPF: 50%YUM: 50%
100% YUM50/50100% TRXPF
Portfolio after 10yr
$317.52M
Annual income
$299,862,158.37/yr
Blended yield
94.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

TRXPF
No analyst data
Altman Z
5.8
Piotroski
3/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRXPF buys
0
YUM buys
0
No recent congressional trades found for TRXPF or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRXPFYUM
Forward yield3.27%1.85%
Annual dividend / share$0.80$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%51.4%
Portfolio after 10y$634.94M$107.0K
Annual income after 10y$599,684,359.43$39,957.33
Total dividends collected$632.35M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: TRXPF vs YUM ($10,000, DRIP)

YearTRXPF PortfolioTRXPF Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$11,354$653.59$10,980$280.44+$374.00TRXPF
2$13,535$1,387.04$12,185$435.72+$1.4KTRXPF
3$17,574$3,090.80$13,722$684.14+$3.9KTRXPF
4$26,305$7,500.82$15,773$1,090.14+$10.5KTRXPF
5$49,132$20,985.78$18,650$1,773.02+$30.5KTRXPF
6$125,837$73,265.77$22,921$2,966.37+$102.9KTRXPF
7$485,391$350,745.93$29,685$5,158.69+$455.7KTRXPF
8$3,048,220$2,528,851.81$41,216$9,453.02+$3.01MTRXPF
9$32,945,707$29,684,110.82$62,672$18,571.31+$32.88MTRXPF
10$634,936,266$599,684,359.43$107,016$39,957.33+$634.83MTRXPF

TRXPF vs YUM: Complete Analysis 2026

TRXPFStock

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Full TRXPF Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this TRXPF vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRXPF vs SCHDTRXPF vs JEPITRXPF vs OTRXPF vs KOTRXPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.